Simplex Trading’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $381K | Buy |
+15,400
| New | +$367K | ﹤0.01% | 3576 |
|
|
2025
Q4 | – | Sell |
-23,800
| Closed | -$468K | – | 8767 |
|
|
2025
Q3 | $468K | Buy |
23,800
+19,100
| +406% | +$393K | ﹤0.01% | 3912 |
|
|
2025
Q2 | $101K | Sell |
4,700
-9,800
| -68% | -$231K | ﹤0.01% | 5227 |
|
|
2025
Q1 | $351K | Buy |
14,500
+9,300
| +179% | +$209K | ﹤0.01% | 3766 |
|
|
2024
Q4 | $108K | Buy |
5,200
+3,600
| +225% | +$77.3K | ﹤0.01% | 5100 |
|
|
2024
Q3 | $31K | Sell |
1,600
-1,500
| -48% | -$27.8K | ﹤0.01% | 6322 |
|
|
2024
Q2 | $48K | Sell |
3,100
-16,500
| -84% | -$257K | ﹤0.01% | 6132 |
|
|
2024
Q1 | $312K | Buy |
19,600
+16,400
| +513% | +$247K | ﹤0.01% | 4337 |
|
|
2023
Q4 | $53K | Sell |
3,200
-14,200
| -82% | -$194K | ﹤0.01% | 6023 |
|
|
2023
Q3 | $203K | Sell |
17,400
-16,800
| -49% | -$225K | ﹤0.01% | 4335 |
|
|
2023
Q2 | $459K | Sell |
34,200
-138,100
| -80% | -$1.99M | ﹤0.01% | 3401 |
|
|
2023
Q1 | $2.86M | Buy |
172,300
+154,300
| +857% | +$2.55M | ﹤0.01% | 1659 |
|
|
2022
Q4 | $334K | Sell |
18,000
-5,500
| -23% | -$84.7K | ﹤0.01% | 3612 |
|
|
2022
Q3 | $301K | Buy |
23,500
+19,000
| +422% | +$225K | ﹤0.01% | 4075 |
|
|
2022
Q2 | $31K | Sell |
4,500
-100
| -2% | -$733 | ﹤0.01% | 7094 |
|
|
2022
Q1 | $38K | Buy |
4,600
+2,600
| +130% | +$18.4K | ﹤0.01% | 7499 |
|
|
2021
Q4 | $13K | Sell |
2,000
-4,100
| -67% | -$27K | ﹤0.01% | 8795 |
|
|
2021
Q3 | $35K | Sell |
6,100
-100
| -2% | -$547 | ﹤0.01% | 7945 |
|
|
2021
Q2 | $35K | Buy |
6,200
+5,993
| +2,895% | +$30.9K | ﹤0.01% | 8074 |
|
|
2021
Q1 | $95K | Buy |
207
+175
| +547% | +$695 | ﹤0.01% | 5811 |
|
|
2020
Q4 | $10K | Sell |
32
-357
| -92% | -$1.2K | ﹤0.01% | 7393 |
|
|
2020
Q3 | $115K | Buy |
389
+102
| +36% | +$399 | ﹤0.01% | 4744 |
|
|
2020
Q2 | $132K | Sell |
287
-124
| -30% | -$557 | ﹤0.01% | 4490 |
|
|
2020
Q1 | $158K | Buy |
+411
| New | +$1.69K | ﹤0.01% | 3859 |
|
|
2019
Q4 | – | Sell |
-300
| Closed | -$159K | – | 7371 |
|
|
2019
Q3 | $159K | Sell |
300
-82
| -21% | -$437 | ﹤0.01% | 3807 |
|
|
2019
Q2 | $146K | Buy |
382
+356
| +1,369% | +$1.54K | ﹤0.01% | 3797 |
|
|
2019
Q1 | $13K | Sell |
26
-86
| -77% | -$253 | ﹤0.01% | 5983 |
|
|
2018
Q4 | $21K | Buy |
112
+73
| +187% | +$209 | ﹤0.01% | 5272 |
|
|
2018
Q3 | $14K | Sell |
39
-310
| -89% | -$971 | ﹤0.01% | 6218 |
|
|
2018
Q2 | $108K | Buy |
+349
| New | +$1.06K | ﹤0.01% | 4203 |
|
|
2015
Q3 | – | Sell |
-164
| Closed | -$5K | – | 5585 |
|
|
2015
Q2 | $5K | Buy |
+164
| New | +$654 | ﹤0.01% | 3635 |
|
Other funds holding CPRX
VCM
DM
VPM
Simplex Trading's CPRX Position: Q1 2026 in Review
Simplex Trading opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 3,811 shares worth $94.4K. The stake represents ﹤0.01% of the portfolio and ranks #5153 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CPRX as recently as Q2 2025.
Simplex Trading first reported a position in CPRX in Q4 2014 and has held it in 30 quarters since. The position peaked at $448K in Q3 2021. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Simplex Trading held 3,811 shares of Catalyst Pharmaceutical worth $94.4K as of Q1 2026.
- Catalyst Pharmaceutical was a new Simplex Trading position in Q1 2026.
- Catalyst Pharmaceutical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5153 holding.
- Simplex Trading first reported a position in Catalyst Pharmaceutical in Q4 2014 and has held it in 30 quarters since.
- Simplex Trading's Catalyst Pharmaceutical position peaked at $448K in Q3 2021.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.